# Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder

> **NCT01551225** · PHASE4 · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 32 (actual)

## Conditions studied

- Irritable Bowel Syndrome
- Panic Disorder

## Interventions

- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT01551225
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551225, "Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01551225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*